Research ArticleTheranostics
Open Access
A Prospective Study on 18F-DCFPyL PSMA PET/CT Imaging in Biochemical Recurrence of Prostate Cancer
Etienne Rousseau, Don Wilson, Frédéric Lacroix-Poisson, Andra Krauze, Kim Chi, Martin Gleave, Michael McKenzie, Scott Tyldesley, S. Larry Goldenberg and François Bénard
Journal of Nuclear Medicine November 2019, 60 (11) 1587-1593; DOI: https://doi.org/10.2967/jnumed.119.226381
Etienne Rousseau
1BC Cancer, Vancouver, British Columbia, Canada
2Department of Radiology, University of British Columbia, Vancouver, British Columbia, Canada; and
Don Wilson
1BC Cancer, Vancouver, British Columbia, Canada
2Department of Radiology, University of British Columbia, Vancouver, British Columbia, Canada; and
Frédéric Lacroix-Poisson
1BC Cancer, Vancouver, British Columbia, Canada
2Department of Radiology, University of British Columbia, Vancouver, British Columbia, Canada; and
Andra Krauze
1BC Cancer, Vancouver, British Columbia, Canada
Kim Chi
1BC Cancer, Vancouver, British Columbia, Canada
Martin Gleave
3Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada
Michael McKenzie
1BC Cancer, Vancouver, British Columbia, Canada
Scott Tyldesley
1BC Cancer, Vancouver, British Columbia, Canada
S. Larry Goldenberg
3Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada
François Bénard
1BC Cancer, Vancouver, British Columbia, Canada
2Department of Radiology, University of British Columbia, Vancouver, British Columbia, Canada; and
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 60, Issue 11
November 1, 2019
A Prospective Study on 18F-DCFPyL PSMA PET/CT Imaging in Biochemical Recurrence of Prostate Cancer
Etienne Rousseau, Don Wilson, Frédéric Lacroix-Poisson, Andra Krauze, Kim Chi, Martin Gleave, Michael McKenzie, Scott Tyldesley, S. Larry Goldenberg, François Bénard
Journal of Nuclear Medicine Nov 2019, 60 (11) 1587-1593; DOI: 10.2967/jnumed.119.226381
A Prospective Study on 18F-DCFPyL PSMA PET/CT Imaging in Biochemical Recurrence of Prostate Cancer
Etienne Rousseau, Don Wilson, Frédéric Lacroix-Poisson, Andra Krauze, Kim Chi, Martin Gleave, Michael McKenzie, Scott Tyldesley, S. Larry Goldenberg, François Bénard
Journal of Nuclear Medicine Nov 2019, 60 (11) 1587-1593; DOI: 10.2967/jnumed.119.226381
Jump to section
Related Articles
Cited By...
- Changes in Management After 18F-DCFPyL PSMA PET in Patients Undergoing Postprostatectomy Radiotherapy, with Early Biochemical Response Outcomes
- Predictors of 18F-DCFPyL PET/CT Positivity in Patients with Biochemical Recurrence of Prostate Cancer After Local Therapy
- 18F-DCFPyL PET Acquisition, Interpretation, and Reporting: Suggestions After Food and Drug Administration Approval
- Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on 18F-Fluciclovine PET/CT Guidance
- The Effects of Monosodium Glutamate on PSMA Radiotracer Uptake in Men with Recurrent Prostate Cancer: A Prospective, Randomized, Double-Blind, Placebo-Controlled Intraindividual Imaging Study
- 18F-DCFPyL PET/CT Imaging in Patients with Biochemically Recurrent Prostate Cancer After Primary Local Therapy
- Appropriate Use Criteria for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer After Definitive Primary Treatment
- Prospective Evaluation of 18F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer in an Academic Center: A Focus on Disease Localization and Changes in Management